CAPTRUST Financial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,936	Closed	-$1.07M	–	4818
2021 Q1	$1.07M	Buy	4,936 +1	+0%	+$188	0.01%	671
2020 Q4	$570K	Buy	4,935 +25	+0.5%	+$2.8K	0.01%	785
2020 Q3	$474K	Hold	4,910	–	–	0.01%	733
2020 Q2	$620K	Buy	4,910 +71	+1%	+$8.05K	0.01%	648
2020 Q1	$411K	Sell	4,839 -175	-3%	-$18.5K	0.01%	633
2019 Q4	$520K	Buy	+5,014	New	+$562K	0.01%	677

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

CAPTRUST Financial Advisors's GWPH Position: Q2 2021 in Review

CAPTRUST Financial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,936 shares — an estimated $1.07M sold.

CAPTRUST Financial Advisors first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $1.07M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

CAPTRUST Financial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 4,936 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.07M.
CAPTRUST Financial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
CAPTRUST Financial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.07M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.